Journal Watch · Proceedings of the National Academy of Sciences (PNAS) · 2026
Proteolytic activation of c-MYC facilitated by DOT1L.
Our results suggest that DOT1L may activate c-MYC and other transcription factors in the nucleus by acting as a protease.
TL;DR
Our results suggest that DOT1L may activate c-MYC and other transcription factors in the nucleus by acting as a protease.
Key findings
- Surprisingly, we found a similarity between a conserved sequence in DOT1 proteins and the DDI-family protease catalytic motif.
- We characterize a c-MYC sequence preceding the DNA-binding domain as a site of nuclear proteolytic cleavage, demonstrate its importance for transcription activation by c-MYC, and propose that c-MYC is activated by a protease, as previously reported for Nuclear factor erythroid 2-related factor (NRF) and SREBP transcription factors.
- Our results suggest that DOT1L may activate c-MYC and other transcription factors in the nucleus by acting as a protease.
What they did
We demonstrate that DOT1L and MYC [Myc and Mondo-like (MML-1) in <i>Caenorhabditis elegans</i>] coregulate genes in the nematode model and mammalian cancer cells. Moreover, both c-MYC and MML-1 exhibit cleavage products facilitated by DOT1L function.
Full abstract (original)
Background: c-MYC is a key regulator of growth and metabolism. Functional and molecular cooperation between the H3K79 methyltransferase DOT1L and c-MYC has been reported in several human cancer types, but the nature of their interaction remains undefined.
What they did: We demonstrate that DOT1L and MYC [Myc and Mondo-like (MML-1) in <i>Caenorhabditis elegans</i>] coregulate genes in the nematode model and mammalian cancer cells. Moreover, both c-MYC and MML-1 exhibit cleavage products facilitated by DOT1L function.
Results & conclusions: Surprisingly, we found a similarity between a conserved sequence in DOT1 proteins and the DDI-family protease catalytic motif. We characterize a c-MYC sequence preceding the DNA-binding domain as a site of nuclear proteolytic cleavage, demonstrate its importance for transcription activation by c-MYC, and propose that c-MYC is activated by a protease, as previously reported for Nuclear factor erythroid 2-related factor (NRF) and SREBP transcription factors. Our results suggest that DOT1L may activate c-MYC and other transcription factors in the nucleus by acting as a protease.
Abstract © the authors / Proceedings of the National Academy of Sciences (PNAS) (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1073/pnas.2525603123 · PubMed 42520114.
Why it matters for pharma & biotech
- Relevant to General & Medicine teams tracking Proceedings of the National Academy of Sciences (PNAS) for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Proceedings of the National Academy of Sciences (PNAS) study find?
Our results suggest that DOT1L may activate c-MYC and other transcription factors in the nucleus by acting as a protease.
What type of study is this?
It is a research study, published in Proceedings of the National Academy of Sciences (PNAS) in 2026. We demonstrate that DOT1L and MYC [Myc and Mondo-like (MML-1) in <i>Caenorhabditis elegans</i>] coregulate genes in the nematode model and mammalian cancer cells.
Where can I read the original paper?
The original is at the publisher via DOI 10.1073/pnas.2525603123. PubMed ID: 42520114. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/proteolytic-activation-of-c-myc-facilitated-by-dot1l-603123/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides